N-acyl-N-naphthoylglycines as aldose reductase inhibitors

Details N-acyl-N-naphthoylglycines as aldose reductase inhibitors N-acyl-N-naphthoylglycines as aldose reductase inhibitors

1989-01-09

1990-05-15

Gray, Bruce

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acid esters

560 28, 564 44, C07C175065

Patent

active

049259687

ABSTRACT:
Disclosed herein are N-acyl-N-naphthoylglycines and methods of their preparation. The N-acyl-N-naphthoylglycines are novel aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.

REFERENCES:
patent: 4391816 (1983-07-01), Sestanj et al.
patent: 4391825 (1983-07-01), Bellini et al.
patent: 4439617 (1984-03-01), Sestanj et al.
patent: 4447452 (1984-05-01), Sestanj
patent: 4568693 (1986-02-01), Sestanj et al.
patent: 4672058 (1987-06-01), Bellini et al.
patent: 4672059 (1987-06-01), Sestanj et al.
patent: 4820727 (1989-04-01), Wrobel et al.
patent: 4843062 (1989-06-01), Sestanj et al.

Affiliated with

Also associated with

Rating

N-acyl-N-naphthoylglycines as aldose reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-acyl-N-naphthoylglycines as aldose reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-N-naphthoylglycines as aldose reductase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-622390